recording an average of over 7 days of heart monitoring. Despite US FDA approval, the Zio Patch has met slow acceptance possibly due to reimbursement hurdles. Explanations for the slow acceptance ...

Zio XT has been recommended by NICE as an option for people with suspected cardiac arrhythmias who would benefit from ECG monitoring for longer than 24 hours, as a lighter, discreet alternative to ...

Learn more about whether iRhythm Technologies, Inc. or Neogen Corporation is a better investment based on AAII's A+ Investor ...

Learn more about whether iRhythm Technologies, Inc. or LivaNova PLC is a better investment based on AAII's A+ Investor grades ...

monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports ...

Zio AT, iRhythm's mobile cardiac telemetry system, is designed to continuously monitor patients’ heart activity for up ...